The following HLA-antigens could be defined, using the standard micro-lymphocytotoxicity test [5] : HLA-A1, A2, A3, Aw23, Aw24, A25, A26, A28, A29, Aw30, Aw31, Aw32, Aw33; B5, B7, B8, B13, B14, B18, B27, Bw35, B37, Bw38, Bw39, Bw40, Bw41, Bw44, Bw45, Bw47, Bw49, Bw50, Bw53, Bw55, Bw56, Bw57, Bw58, Bw60, Bw61, Bw62, Bw63, Cw1, Cw2, Cw3, Cw4, Cw5. Bf polymorphism (BfS, F, SO.7, F1) was analysed by thin layer high voltage agarose electrophoresis and subsequent immunofixation with Bf antisera (Behring-Werke) as described by Alper et al. [3] and Reuter and Hoffman [7] . All BfFl and BfSO.7 results were corroborated by typing relatives. Table 1 . HLA and Bf phenotype frequencies, BfF1, B18 haplotype frequency (hf) and its gametic association (delta value) in patients with Type 1 diabetes and normal controls. (If there is no association between two genes at two linked loci, they are in linkage equilibrium, and the frequency of their occurrence together (= haplotype frequency) must be the product of the gene frequencies. If the two genes are positively or negatively associated, they are in linkage disequilibrium, the haplotype frequency deviates from the expected gene product and the deviation is expressed by the so-called linkage disequilibrium parameter or delta value.)
Insulin-dependent (Type 1) diabetes mellitus shows a significant positive association not only with HLADw3/DR3 and HLA-Dw4/DR4 [1, 2] but also with BfF1, a rare gene product of the properdin factor B system which is linked to HLA [3, 4] . In this study a group of patients with Type 1 diabetes mellitus was typed for HLA-A, B, C antigens and Bf phenotypers. The HLA and Bf associations with Type 1 diabetes and the linkage disequilibrium between HLA-B18 and BfF1 were investigated in relation to age at onset of disease. Bf and HLA phenotype frequencies of the patients were compared with corresponding control values [6] by chi-square tests with Yates' correction. lILA-Bf haplotype frequencies and linkage disequilibrium parameters (delta, D) were calculated by standard methods [8] [9] [10] . Relative delta values of HLA-B18, BfFl in Type 1 diabetic patients and controls were computed according to Dausset et al. [11] and compared for significance by 2 X 2 X 2 contingency tables as given in detail elsewhere [12] .
Material and Methods

Results
As expected HLA-B8, -B15 and -Cw3 antigen frequencies were significantly increased in the patient group. However, minor differences in frequencies of B7 (decreased) and B18 (increased) were not statistically significant (Table 1) .
One Bf gene product showed a major deviation: the rare variant BfFl was significantly increased (6.0% versus 1.9%, p = 10- Of the 20 BfFl-positive patients, 17 were also positive for B18, indicating a strong association between the B18 and BfFI genes (d = 0.0244). In normal controls the gametic association of B18 and BfFI is much weaker (d = 0.0038) [6] . An increased B18, BfFI haplotype frequency was also found in the diabetics (0.0270 versus 0.0044 in controls). For comparison of the absolute delta values the relative delta values have been calculated. The difference between the Type 1 diabetic patients and normal controls was highly significant (p = 3 X 10-5 ).
The data were also analysed in relation to the age of the patients at the time of onset of diabetes and compared with the findings in controls. As shown in Table 2 , a significantly increased frequency of BfFI was found in the patients under 11 years of age which is even weaker than in normal controls (d = 0.4368). The HLA antigen frequencies were also analysed in relation to the age of the patients at the onset of diabetes ( Table 2 ). The frequency of B18 was almost identical in all three age groups and only slightly increased relative to controls. The youngest patients (0-10 years) showed the highest frequency of B15 and the lowest of B7, these differences from older patients being statistically significant (Table 2) .
Discussion
There are three significant findings of this study: the increased frequency of the rare properdin factor B allele BfFl, the very strong linkage disequilibrium between BfFI and the B18 genes, and the age relationship of the BfFI association with diabetes as well as of the strength of this gametic association.
Increased BfFI frequency in Type 1 diabetic patients was first reported independently by Bertrams et al. [12] and by Alper (Third Workshop on the Genetics of the Complement System 1979; see also [13] ), and was confirmed by others [14] [15] [16] [17] [18] . The great differences in the strength of the association reported by different authors can be explained by its strong age relationship [15, 18, 19] .
Another result of our study is the pronounced increase of B15 in the youngest patients (0-10 years) and the trend of a decreasing frequency of B15 in patients with later manifestation of Type 1 diabetes (11-15 and 16-29 years), as also shown by Dausset [20] and Kirk et al. [15] . The frequency of B7 was very low in the youngest age group (0-10 years). Thus Type 1 diabetes mellitus may develop early in life predominantly in BfFl-and Bl5-positive and B7-negative individuals.
The most striking finding of this study is the marked linkage disequilibrium between BfFI and B18 genes in Type 1 diabetes (d = 0.0244), which is significantly stronger than in normal controls
This very strong linkage disequilibrium is also age related and could be demonstrated only in children who were under 16 years of age at the onset of the disease.
Thus we have been able to demonstrate another HLA linkage group indicating increased susceptibility to Type 1 diabetes, namely BfFl, B18, in addition to the well known 'high risk' gene complexes HLA-AI, B8, Dw3/DR3 and HLA-A2, Cw3, B15, Dw4/ DR4.
As shown by the Type 1 diabetes study of the last Histocompatibility Workshop [21] the BfFl and BI8 genes are also linked to HLA-DR3. Further studies should investigate whether the increase of BfFI in Type 1 diabetes is secondary to the increase of HLA-DR3 or whether it stands for functional involvement of this rare complement variant in the pathogenesis of the disease.
